Related Experiment Video
Updated: Feb 28, 2026
08:05
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
8.4K
The impact of vaccination on RBC alloimmunization in a murine model
P Natarajan1, M Santhanakrishnan1, C A Tormey1,2
1Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.
Vox Sanguinis
|June 10, 2017
Summary
Vaccinations can influence red blood cell (RBC) alloantibody formation. Pneumovax23 reduced anti-KEL alloimmunization in mice, but hepB vaccine had no effect, indicating complex immune interactions.
Area of Science:
- Immunology
- Transfusion Medicine
- Vaccinology
Background:
- Pathogen- and damage-associated molecular patterns can affect red blood cell (RBC) alloantibody formation.
- Understanding these interactions is crucial for transfusion safety and vaccine development.
Purpose of the Study:
- To investigate whether vaccinations enhance immune responses to transfused RBCs.
- To test the hypothesis that pre-existing immunity from vaccines impacts RBC alloimmunization.
Main Methods:
- A murine model was used to assess the impact of Pneumovax23 and hepB vaccines on RBC alloimmunization.
- Mice received vaccinations followed by RBC transfusions to evaluate alloantibody responses.
Main Results:
- Pneumovax23 significantly decreased the magnitude of anti-KEL alloimmunization in the murine model.
- The hepB vaccine did not alter anti-KEL alloimmunization responses.
- RBC transfusion did not affect immune responses to either vaccine.
Conclusions:
- Vaccinations can modulate RBC alloantibody formation, but the effects are vaccine-specific.
- These findings underscore the intricate interplay between innate and adaptive immunity in transfusion medicine.
- Further research into inflammation's role in alloimmunization pathways is warranted.
